Jeena Sikho Lifecare Limited has released its investor presentation for Q3 FY 2025-26, detailing its financial performance and strategic initiatives. The company reported a significant year-over-year revenue growth of 92% in Q3, reaching ₹221.66 crore. This performance was driven by a 17% quarter-over-quarter increase and sustained volume expansion across its business segments, particularly in Ayurveda healthcare services and products. Profitability remained strong, with EBITDA margins steady at 45% in Q3. For the nine-month period of FY26 (9MFY26), EBITDA margins improved to 46% compared to 29% in FY25, indicating enhanced scalability and efficiency. The services segment saw robust patient volumes in both IPD and OPD formats, with notable traction in Day Care centers and Video-Call consultations. The company is set to launch the Jeena Sikho Health Card to offer enhanced customer value. Furthermore, the Ayurveda healthcare products segment continues to grow, supported by new product launches and demand for its existing portfolio. Looking ahead, Jeena Sikho Lifecare Limited plans capacity expansion with over 475 beds under development and is exploring international expansion. The presentation also provided a detailed overview of the company's business model, market approach, operational reach, and financial milestones. Key financial highlights for Q3FY26 included Revenue from Operations at ₹22,166 lakhs, EBITDA at ₹10,080 lakhs, and Profit After Taxes at ₹6,673 lakhs. Basic Earnings Per Share (EPS) stood at ₹5.37 for the quarter.
